VCV002011646.3 - ClinVar

NM_005138.3(SCO2):c.45_46del (p.Gln16fs)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(2)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Pathogenic/Likely pathogenic

criteria provided, multiple submitters, no conflicts

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_005138.3(SCO2):c.45_46del (p.Gln16fs)

Variation ID: 2011646 Accession: VCV002011646.3

Type and length

Microsatellite, 2 bp

Location

Cytogenetic: 22q13.33 22: 50524366-50524367 (GRCh38) [ NCBI UCSC ] 22: 50962795-50962796 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Feb 8, 2023	Feb 20, 2024	Jan 7, 2024

HGVS

Nucleotide	Protein	Molecular consequence
NM_005138.3:c.45_46del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_005129.2:p.Gln16fs	frameshift
NM_152299.4:c.*992AG[2] MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.		3 prime UTR
NM_001169109.2:c.45_46del	NP_001162580.1:p.Gln16fs	frameshift
NM_001169110.1:c.45_46del	NP_001162581.1:p.Gln16fs	frameshift
NM_001169111.2:c.45_46del	NP_001162582.1:p.Gln16fs	frameshift
NM_001185011.2:c.*992AG[2]		3 prime UTR
NC_000022.11:g.50524367AG[2]
NC_000022.10:g.50962796AG[2]
NG_011860.1:g.10715TC[2]
NG_016235.1:g.7069TC[2]
NG_021419.1:g.21152AG[2]
LRG_727:g.10715TC[2]

... more HGVS ... less HGVS

Protein change

Q16fs

Other names

Canonical SPDI

NC_000022.11:50524365:GAGAGAG:GAGAG

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
NCAPH2		-	-	GRCh38 GRCh37	53	573
SCO2		-	-	GRCh38 GRCh37	4	884

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
not provided	Pathogenic (1)	criteria provided, single submitter	Jan 7, 2024	RCV002838566.3
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	Likely pathogenic (1)	criteria provided, single submitter	Sep 2, 2023	RCV003475434.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (Sep 02, 2023)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 Affected status: unknown Allele origin: unknown	Baylor Genetics Accession: SCV004202361.1 First in ClinVar: Dec 30, 2023 Last updated: Dec 30, 2023
Pathogenic (Jan 07, 2024)	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015)) Method: clinical testing	not provided Affected status: unknown Allele origin: germline	Labcorp Genetics (formerly Invitae), Labcorp Accession: SCV003217730.2 First in ClinVar: Feb 07, 2023 Last updated: Feb 20, 2024	Publications: PubMed (3) PubMed: 19353847‚ 29193756‚ 32600061 Comment: This sequence change creates a premature translational stop signal (p.Gln16Alafs65) in the SCO2 gene. While this is not anticipated to result in nonsense mediated decay, … (more) This sequence change creates a premature translational stop signal (p.Gln16Alafs65) in the SCO2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 251 amino acid(s) of the SCO2 protein. This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SCO2-related conditions. This variant disrupts a region of the SCO2 protein in which other variant(s) (p.Gly193Ser) have been determined to be pathogenic (PMID: 19353847, 29193756, 32600061). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. (less)

Comment:

This sequence change creates a premature translational stop signal (p.Gln16Alafs*65) in the SCO2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 251 amino acid(s) of the SCO2 protein. This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SCO2-related conditions. This variant disrupts a region of the SCO2 protein in which other variant(s) (p.Gly193Ser) have been determined to be pathogenic (PMID: 19353847, 29193756, 32600061). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Increased Burden of Ion Channel Gene Variants Is Related to Distinct Phenotypes in Pediatric Patients With Left Ventricular Noncompaction.	Hirono K	Circulation. Genomic and precision medicine	2020	PMID: 32600061
Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.	Hallas T	Journal of cellular and molecular medicine	2018	PMID: 29193756
A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy.	Mobley BC	Clinical neuropathology	2009	PMID: 19353847

Text-mined citations for this variant ...

Record last updated Sep 29, 2024

ClinVar Genomic variation as it relates to human health

NM_005138.3(SCO2):c.45_46del (p.Gln16fs)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...